Marty Richard

Marty Richard currently serves as Vice President of GXP Quality at Edgewise Therapeutics since June 2024 and has been Vice President of GXP Quality/Compliance at BioMarin Pharmaceutical Inc. since August 2011, focusing on Technical Operations Compliance. Marty holds a Bachelor of Arts degree in Molecular and Cellular Biology from the University of Arizona, complemented by minors in Math and Chemistry. Additional certifications include ASQ Certified Quality Auditor and European Compliance Academy Certified ICH Q7 Auditor for APIs. Marty also completed a GCP Compliance Overview course at the University of California, Berkeley.